{
  "meta": {
    "id": "test64",
    "title": "Neurology-Guillian_Barre_Syndrome_and_Alzheimer_s_disease",
    "category": "Prepladder / RR"
  },
  "questions": [
    {
      "text": "A 30-year-old man from North America presents to the emergency department with rapidly progressing muscle weakness over the past two weeks. He reports having had a mild gastrointestinal illness a few weeks prior. On examination, he exhibits areflexia and difficulty with eye movements. Electrophysiological studies indicate demyelination. Which of the following variants of Guillain-Barr\u00e9 Syndrome is most likely associated with this patient's presentation?",
      "options": [
        {
          "label": "A",
          "text": "Acute inflammatory demyelinating polyneuropathy (AIDP)",
          "correct": true
        },
        {
          "label": "B",
          "text": "Axonal variant",
          "correct": false
        },
        {
          "label": "C",
          "text": "Miller Fisher Syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute inflammatory demyelinating polyneuropathy (AIDP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Aspect</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Details</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Definition</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>A group of immune-mediated conditions causing <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> paralysis, with the most common <span class=\"customMeta\" data-dictid=\"0efdcdc9e01692777201003c81c85a\">variant</span> being <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> <span class=\"customMeta\" data-dictid=\"25cf8215eb1692777186f0ab76dc34\">demyelinating polyneuropathy</span> (AIDP).</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Incidence</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1\u20132 cases per 100,000 individuals per year.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Common Preceding Infections</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>About two-thirds of AIDP cases have a prior history of infection, often triggering an <span class=\"customMeta\" data-dictid=\"96ab11a06a16927771823151c8e471\">autoimmune</span> response leading to demyelination.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Variant</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Acute <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">Inflammatory</span> <span class=\"customMeta\" data-dictid=\"25cf8215eb1692777186f0ab76dc34\">Demyelinating Polyneuropathy</span> (AIDP)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>The most common <span class=\"customMeta\" data-dictid=\"0efdcdc9e01692777201003c81c85a\">variant</span> is in Europe & North America.</li>\n<li>Patchy <span class=\"customMeta\" data-dictid=\"6c572343621692777198867cf8d853\">segmental</span> <span class=\"customMeta\" data-dictid=\"336cefd9041692777185a8959344f8\">demyelination</span> of <span class=\"customMeta\" data-dictid=\"d816ba952f1692777199fc69bd7c56\">spinal</span> cord and <span class=\"customMeta\" data-dictid=\"255674f3271692777195c172d86daf\">peripheral</span> nerves</li>\n<li><strong>Antibodies seen:</strong>\n<ul>\n<li>IgG <span class=\"customMeta\" data-dictid=\"4665fdd0a0169277718100f58eb0d5\">Anti</span> GM1</li>\n<li>IgG <span class=\"customMeta\" data-dictid=\"4665fdd0a0169277718100f58eb0d5\">Anti</span> GQ1b</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Axonal Variants</strong></p>\n<p><strong>(Option B ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>More prevalent in China and Japan; account for 10% of <span class=\"customMeta\" data-dictid=\"aa23182e651692777188296980e246\">GBS</span> cases in Western countries; often associated with <span class=\"customMeta\" data-dictid=\"a61219530816927771837697e1555e\">Campylobacter</span> jejuni infection.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Miller Fisher Syndrome</strong></p>\n<p><strong>(Option C ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Best-recognised variant.</p>\n<p>Associated with anti-GQ1b antibodies.</p>\n<p>Presents with internal and external ophthalmoplegia, ataxia, and areflexia.</p>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "16a5f35e"
    },
    {
      "text": "A recent study on autoantibodies associated with Guillain-Barr\u00e9 syndrome (GBS) revealed important findings. Which of the following statements about the role of autoantibodies in GBS is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "Anti-ganglioside antibodies are rarely found in GBS patients and have no prognostic significance.",
          "correct": false
        },
        {
          "label": "B",
          "text": "The presence of anti-GM1 antibodies correlates with better clinical outcomes in GBS patients.",
          "correct": false
        },
        {
          "label": "C",
          "text": "A diverse array of autoantibodies targeting nerve components suggests multiple immune mechanisms contribute to GBS pathology.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Specific autoantibodies are only directed against gangliosides, with no other targets identified in GBS pathology.",
          "correct": false
        }
      ],
      "correct_answer": "C. A diverse array of autoantibodies targeting nerve components suggests multiple immune mechanisms contribute to GBS pathology.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:614px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Aspect</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Details</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Diversity of Autoantibodies</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>GBS patients exhibit a wide range of autoantibodies <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> nerve cells and structures, indicating multiple immune mechanisms may contribute to <span class=\"customMeta\" data-dictid=\"aa23182e651692777188296980e246\">GBS</span> pathology.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Prevalence of Anti-Ganglioside Antibodies</strong></p>\n<p><strong>(Option A ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Anti-ganglioside antibodies</strong> are the <strong>most common</strong>, detected in up to 50% of <span class=\"customMeta\" data-dictid=\"aa23182e651692777188296980e246\">GBS</span> patients, often arising from <span class=\"customMeta\" data-dictid=\"04f4b6dbf71692777192ca0c4f70fa\">microbial</span> molecular mimicry.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Prognostic Implications</strong></p>\n<p><strong>(Option B ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Specific autoantibodies, especially <strong>anti-GM1</strong>, are associated with poorer clinical outcomes.</li>\n<li>Presence correlates with variants like pure motor variants and Miller-Fisher syndrome.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Target Antigens</strong></p>\n<p><strong>(Option D ruled out)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>While gangliosides are primary targets, other potential targets include nodal and paranodal proteins (e.g., neurofascin), suggesting a broader spectrum of <span class=\"customMeta\" data-dictid=\"06e07ce7821692777182e8ffd9676f\">autoantibody</span> involvement.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Clinical-Immunological Correlations</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Research aims to establish correlations between <span class=\"customMeta\" data-dictid=\"aa23182e651692777188296980e246\">GBS</span> clinical presentations and specific autoantibodies, enhancing understanding of immune responses in relation to patient outcomes.</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "7cbe9e10"
    },
    {
      "text": "Which of the following statements is incorrect regarding the types of Guillain-Barr\u00e9 syndrome?",
      "options": [
        {
          "label": "A",
          "text": "AIDP is the most common form in adults.",
          "correct": false
        },
        {
          "label": "B",
          "text": "AMSAN has a better prognosis than AMAN.",
          "correct": true
        },
        {
          "label": "C",
          "text": "AMAN involves axonal degeneration in children and young adults",
          "correct": false
        },
        {
          "label": "D",
          "text": "Miller-Fisher syndrome is associated with anti-GQ1b antibodies",
          "correct": false
        }
      ],
      "correct_answer": "B. AMSAN has a better prognosis than AMAN.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:676px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Type</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Features</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Neural Target</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Electrodiagnostic Study</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>AIDP (Acute <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">Inflammatory</span> Demyelinating Polyneuropathy)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Most common in adults <strong> (Option A)</strong></li>\n<li>Rapid recovery</li>\n<li>IgG Anti-GM1 a/b</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Schwann cells</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Demyelination</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>AMAN (Acute Motor Axonal Neuropathy) </strong><strong> </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Seen in children and young adults <strong>(Option C)</strong></li>\n<li>Poor prognosis</li>\n<li>IgG Anti-GM1 a/b</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Nodes of Ranvier</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>AMSAN (Acute Motor <span class=\"customMeta\" data-dictid=\"408bcde7f01692777198acadb8e1c6\">Sensory</span> Axonal Neuropathy) </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Uncommon</li>\n<li>Seen in adults</li>\n<li>Worst prognosis</li>\n<li>IgG Anti-GM1 a/b</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Nodes of Ranvier</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Miller <span class=\"customMeta\" data-dictid=\"427e4a7ec6169277720233b7958c69\">Fisher Syndrome</span> </strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li><strong>Triad:</strong> Ophthalmoplegia, Areflexia, Ataxia</li>\n<li>Seen in 5% of cases</li>\n<li>Anti-GQ1b <strong>(Option D)</strong></li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Identical to AIDP</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Either <span class=\"customMeta\" data-dictid=\"336cefd9041692777185a8959344f8\">demyelination</span> or axonal degeneration</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "4c6aec71"
    },
    {
      "text": "A 35-year-old man presents with a 2-day history of progressive weakness that started in his legs after returning from his international trip. He has difficulty climbing stairs, increasing fatigue with normal activities, and mild tingling in his feet. He has a recent history of mild flu-like symptoms, including fever and malaise. On examination, he shows weakness in both lower extremities with reduced muscle tone and absent deep tendon reflexes. Laboratory findings reveal that CSF analysis showed elevated protein with a normal cell count. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Guillain-Barr\u00e9 syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Tick paralysis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Myasthenia gravis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Poliomyelitis",
          "correct": false
        }
      ],
      "correct_answer": "A. Guillain-Barr\u00e9 syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Category</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Motor Symptoms</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li><strong>Progressive <span class=\"customMeta\" data-dictid=\"62f0d7c8491692777182ab7cc82edb\">ascending</span> paralysis</strong> <strong>(distal to proximal)</strong></li>\n<li>Areflexia</li>\n<li>Weakness in legs causing rubbery legs and <span class=\"customMeta\" data-dictid=\"acb259200b16927771908888d1377c\">instability</span> to stand</li>\n<li>Truncal paralysis, quadriplegia, neck floppiness</li>\n<li>Bilateral 7th nerve palsy</li>\n<li>Bulbar palsy\n\t\t\t\t<ul>\n<li>Difficulty in handling secretions leading to <span class=\"customMeta\" data-dictid=\"831d67ad8a1692777182763ca62e4b\">aspiration</span> pneumonia</li>\n<li>A leading <span class=\"customMeta\" data-dictid=\"254dc5106d1692777183ba9ab1b3e5\">cause of death</span> due to <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> involvement.</li>\n</ul>\n</li>\n<li>Diaphragmatic paralysis\n\t\t\t\t<ul>\n<li>Ventilatory support is required in 30% of cases.</li>\n<li>Increased <span class=\"customMeta\" data-dictid=\"c32b3a9fac16927771831530888fdf\">carbon dioxide</span> levels.</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Sensory Symptoms</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Glove-and-stocking distribution paresthesias</li>\n<li>Proprioception loss\n\t\t\t\t<ul>\n<li>Difficulty in climbing stairs</li>\n<li>Pain in the neck/arm/shoulder is similar to over-exercised muscle</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Sensory manifestations can occur before or along with motor manifestations.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Autonomic Symptoms</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Autonomic <span class=\"customMeta\" data-dictid=\"3704fc52401692777186c42775c9fb\">dysregulation</span> (e.g., <span class=\"customMeta\" data-dictid=\"32742bce4316927771941ff62a9db7\">orthostatic</span> hypotension, bladder/bowel sparing/transient involvement)</li>\n<li>Wide fluctuations of blood pressure, arrhythmias, postural hypotension</li>\n<li>Reduced heart rate and blood pressure, <span class=\"customMeta\" data-dictid=\"fec88fc386169277719326fdef547f\">neurogenic</span> shock.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "36694593"
    },
    {
      "text": "A 40-year-old man presents with a 3-day history of progressive weakness, initially localized to his legs but now involving the arms. He reports increased difficulty with tasks such as buttoning his shirt and climbing stairs, along with episodes of fatigue during minimal exertion. He also describes a tingling sensation in his fingers and has experienced mild fever and generalized malaise over the past week. On examination, he demonstrates significant weakness in all four extremities, reduced muscle tone, and absent deep tendon reflexes. What is the next best step in the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Lumbar puncture for cerebrospinal fluid analysis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Nerve conduction studies",
          "correct": false
        },
        {
          "label": "C",
          "text": "Serum acetylcholine receptor antibodies test",
          "correct": false
        },
        {
          "label": "D",
          "text": "Polymerase chain reaction for poliovirus",
          "correct": false
        }
      ],
      "correct_answer": "A. Lumbar puncture for cerebrospinal fluid analysis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Category</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Findings</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Lumbar Puncture</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>CSF protein: 100-1000 mg/dL</li>\n<li>Elevated <span class=\"customMeta\" data-dictid=\"123c47549916927771854892334fb9\">CSF</span> protein but normal <span class=\"customMeta\" data-dictid=\"09be7d1f11169277720210bf5b0280\">WBC</span> count (albuminocytologic dissociation)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>CSF Study Timing</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Normal <span class=\"customMeta\" data-dictid=\"123c47549916927771854892334fb9\">CSF</span> findings (<48 hours)</li>\n<li>Maximum rise of protein seen by 7 days</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Electrodiagnostic Testing</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Prolonged F-wave latencies\n\t\t\t\t<ul>\n<li>Earliest finding in AIDP (Acute <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">Inflammatory</span> Demyelinating Polyneuropathy)</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Criteria</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Flaccid <span class=\"customMeta\" data-dictid=\"625feb7e3a1692777183aa9d923cfd\">Bilateral</span> Weakness</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Weakness of limbs (flaccid).</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Areflexia</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Areflexia is present in areas of weakness.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>CytoAlbuminologic dissociation</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Elevated <span class=\"customMeta\" data-dictid=\"123c47549916927771854892334fb9\">CSF</span> protein with normal <span class=\"customMeta\" data-dictid=\"09be7d1f11169277720210bf5b0280\">WBC</span> count.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Monophasic Illness</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Symptoms develop over 12 hours to 28 days.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Electrodiagnostic</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Electrodiagnostic findings are consistent with demyelination.</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "00595c85"
    },
    {
      "text": "A 50-year-old man presents with generalized weakness and inability to walk due to loss of balance after a recent viral illness. He reports double vision, and examination reveals bilateral ptosis and global areflexia. He has a history of alcohol use but is non-diabetic and non-hypertensive. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Intravenous immunoglobulin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Corticosteroids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thiamine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pyridostigmine",
          "correct": false
        }
      ],
      "correct_answer": "A. Intravenous immunoglobulin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:647px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Treatment</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Details</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>IVIG</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Treatment of choice (TOC)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Plasmapheresis (Plex)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Equally effective as IVIG; use either</li>\n<li>Functional improvement may occur >1 week after treatment or show delayed response<strong> </strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Glucocorticoids</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Not useful in this condition<strong> (Option B)</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Monitoring</strong></p>\n</td>\n<td rowspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Frequent assessment of <span class=\"customMeta\" data-dictid=\"c678bddb1d1692777192d2ee1ebd92\">maximal</span> negative inspiratory force (NIF) and vital capacity</li>\n</ul>\n<ul>\n<li>Determines need for <span class=\"customMeta\" data-dictid=\"dcf52bc6051692777189bc6d95b5e5\">ICU</span> admission due to impending <span class=\"customMeta\" data-dictid=\"cfad80a0f716927771979aae100f95\">respiratory</span> failure</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\u00a0</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p><strong>Rehabilitation</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<ul>\n<li>Aggressive physical rehabilitation is imperative</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "5a528381"
    },
    {
      "text": "A 20-year-old female presents with acute dysphagia, particularly for liquids, and nasal regurgitation, following a recent dengue fever. Examination reveals bilateral facial weakness and areflexia in the upper limbs. Brain and cervical spine MRI is normal, while cerebrospinal fluid analysis shows elevated protein with normal glucose. What is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Acute pharyngeal cervicobrachial neuropathy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Miller-Fisher syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Multiple sclerosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Botulism",
          "correct": false
        }
      ],
      "correct_answer": "A. Acute pharyngeal cervicobrachial neuropathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "da4e1179"
    },
    {
      "text": "A 75-year-old man presents with progressive memory loss, difficulty in performing daily activities, and mood changes. His family notes that he often repeats the same questions and becomes easily confused. Neurological examination reveals no focal deficits, but cognitive testing indicates significant impairment in memory and language skills. What is the possible neurotransmitter status for this condition?",
      "options": [
        {
          "label": "A",
          "text": "Increased Acetylcholine, decreased Norepinephrine, decreased Serotonin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decreased Acetylcholine, decreased Norepinephrine, decreased Serotonin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Normal Acetylcholine, increased Norepinephrine, normal Serotonin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased Acetylcholine, increased Norepinephrine, decreased Serotonin",
          "correct": false
        }
      ],
      "correct_answer": "B. Decreased Acetylcholine, decreased Norepinephrine, decreased Serotonin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:535px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p style=\"text-align: center;\"><strong>Neurotransmitter</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p style=\"text-align: center;\"><strong>Location of Synthesis</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Decreased ACh</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Nucleus <span class=\"customMeta\" data-dictid=\"849623f7a71692777182fb29760194\">basalis</span> of Meynert (forebrain)</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Decreased Norepinephrine</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Locus <span class=\"customMeta\" data-dictid=\"7ab09b1b141692777184616deb49e2\">coeruleus</span> (pons)</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Decreased Serotonin</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:middle\">\n<p>Dorsal <span class=\"customMeta\" data-dictid=\"127f1d277616927771975f15621776\">raphe</span> (brainstem)</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "5bee9bea"
    },
    {
      "text": "A 30-year-old man with Down syndrome is being monitored for cognitive decline due to his increased risk for Alzheimer's disease. Why is this patient at a higher risk for developing Alzheimer's disease?",
      "options": [
        {
          "label": "A",
          "text": "Presenilin 1 gene mutation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Overexpression of the APP gene",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mutation in the ApoE4 gene",
          "correct": false
        },
        {
          "label": "D",
          "text": "Release of pro-inflammatory cytokines and promoting insulin resistance",
          "correct": false
        }
      ],
      "correct_answer": "B. Overexpression of the APP gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:590px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Chromosome 1</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Presenilin 2 gene defective</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Chromosome 14</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Presenilin 1 gene defective<strong> (Option A ruled out)</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Chromosome 19</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>ApoE gene</p>\n<p>ApoE4 allele: Higher risk of developing <span class=\"customMeta\" data-dictid=\"a325d0c14e16927771992fe8a96758\">sporadic</span> Alzheimer's disease <strong> (Option C ruled out)</strong></p>\n<p>ApoE2 allele: Low risk</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Chromosome 21</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>The <span class=\"customMeta\" data-dictid=\"51ad856e041692777181f80c9d507a\">amyloid</span> <span class=\"customMeta\" data-dictid=\"ae13cdc5c3169277719683e9f6bda5\">precursor</span> protein (APP) gene</p>\n<p>Alzheimer's Disease in <span class=\"customMeta\" data-dictid=\"e8be57a3f316927771864f46a8ea54\">Down syndrome</span> (extra copy of <span class=\"customMeta\" data-dictid=\"7157c1f59916927771846116d74646\">chromosome</span> 21 leads to overexpression of the <span class=\"customMeta\" data-dictid=\"351e627bcf1692777181d406512336\">APP</span> gene) <strong>(Option B)</strong></p>\n<p>Early-age-of-onset <span class=\"customMeta\" data-dictid=\"5dda3cc2ab1692777202b3b3c65bea\">familial</span> AD</p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "94addd04"
    },
    {
      "text": "Which of the following neurodegenerative disorders is not classified as a tauopathy?",
      "options": [
        {
          "label": "A",
          "text": "Alzheimer\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Punch-drunk syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Parkinson\u2019s disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pantothenate kinase-associated neurodegeneration (PKAN)",
          "correct": false
        }
      ],
      "correct_answer": "C. Parkinson\u2019s disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "0b4907af"
    },
    {
      "text": "A 60-year-old woman has been diagnosed with early-stage Alzheimer's disease. Her husband reports that she frequently struggles to remember recent events and has begun to repeat herself in conversations. Additionally, she has difficulty managing her finances and has gotten lost while driving to familiar places. Despite these issues, she insists that she is \u201cjust fine\u201d and is not concerned about her memory. Which term best describes the unawareness of her cognitive decline?",
      "options": [
        {
          "label": "A",
          "text": "Subjective cognitive decline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anosognosia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Apraxia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mild cognitive impairment (MCI)",
          "correct": false
        }
      ],
      "correct_answer": "B. Anosognosia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "a8f64ab1"
    },
    {
      "text": "A 74-year-old woman is brought to a memory clinic by her daughter, who reports increasing forgetfulness over the past year. The daughter notes that her mother often misplaces items, struggles to find the right words during conversations, and repeats questions she has just asked. Recently, she became lost while driving to her regular grocery store, which she has frequented for years. On examination, she has difficulty following a conversation, and signs of apraxia are present. There are no significant findings on routine laboratory tests, and an FDG-PET is ordered. Which finding in FDG-PET is most consistent with the diagnosis of this patient\u2019s condition?",
      "options": [
        {
          "label": "A",
          "text": "Hypometabolism in the posterior temporal-parietal cortex",
          "correct": true
        },
        {
          "label": "B",
          "text": "Cerebral atrophy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Widened third ventricle",
          "correct": false
        },
        {
          "label": "D",
          "text": "Detection of amyloid depositions",
          "correct": false
        }
      ],
      "correct_answer": "A. Hypometabolism in the posterior temporal-parietal cortex",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/qyXhAPnWbRmGbeuplgPm1744371697.png",
        "https://image.prepladder.com/notes/sL2hm9UMxLhkFKjdJDJZ1744372796.png"
      ],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:742px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Vascular Dementia</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Alzheimer\u2019s disease</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Frontotemporal Dementia</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Creutzfeldt-</strong></p>\n<p><strong>Jakob disease</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Lewy-body Dementia</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Molecular basis</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>A\u03b2/tau</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Tau,TDP-43,FET</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>PrPSC</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>\u03b1-Synuclein</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Features</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Step-wise cognitive decline, often following strokes or infarcts.</p>\n<p><strong>Memory impairment</strong> occurs later.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Progressive memory loss, disorientation, and confusion. <strong>Aphasia</strong>, <strong>apraxia</strong>, and <strong>agnosia</strong>.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Early changes in personality and behavior, or <span class=\"customMeta\" data-dictid=\"9b5386bf6216927771812526afb5e6\">aphasia</span> (primary progressive aphasia)</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Rapidly progressive <span class=\"customMeta\" data-dictid=\"41cc5ad93c169277718553c6b948a3\">dementia</span> with <strong>myoclonus</strong>, <strong>ataxia</strong>, and <strong>startle myoclonus</strong>.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Visual hallucinations, fluctuating cognition, <span class=\"customMeta\" data-dictid=\"7bdd34850816927771973c86f95b79\">REM</span> sleep behavior disorder, parkinsonism.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Imaging</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Multiple infarcts</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Cortical atrophy, especially in the <strong>hippocampus</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Frontal/Temporal <span class=\"customMeta\" data-dictid=\"d7dd6ae43c1692777191cf75c0bd58\">lobe</span> atrophy</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>cortical hyperintensity especially <strong>basal ganglia</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Cortical atrophy, especially in <strong>occipital lobes</strong></p>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "4c81e0a4"
    },
    {
      "text": "A 75-year-old woman with moderate Alzheimer's disease has been on Donepezil for the past year. On routine follow-up, her cognitive abilities are declining further, and the physician decides to add another medication. Which treatment would be most appropriate to consider at this stage?",
      "options": [
        {
          "label": "A",
          "text": "Rivastigmine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Memantine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Aducanumab",
          "correct": false
        },
        {
          "label": "D",
          "text": "Galantamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Memantine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "4286063a"
    },
    {
      "text": "Which of the following is NOT part of the clinical triad of Normal Pressure Hydrocephalus (NPH)?",
      "options": [
        {
          "label": "A",
          "text": "Ataxia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urinary incontinence",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dementia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Visual disturbances",
          "correct": true
        }
      ],
      "correct_answer": "D. Visual disturbances",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/notes/uwvMcv8b4oUMHYMl01cz1744373232.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "",
      "video": "",
      "uid": "e87936d2"
    }
  ]
}